查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1521102

生物醫用紡織品市場－2024年至2029年預測

Biomedical Textiles Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預測2024-2029年期間，全球生物醫學紡織品市場將以6.5%的複合年成長率成長。

全球生物醫用紡織品市場受到心血管、整形外科、脊椎和其他疾病發生率上升等幾個核心因素的推動。根據聯合國預測，全球65歲及以上人口預計將從2022年的10%增加到2050年的16%。到 2050 年，老年人口數量將超過五歲以下兒童。這給了很大一部分人口與整形外科、心血管等相關的嚴重健康問題，並增加了對生物醫學紡織品等創新保健產品的需求。生物醫學紡織品市場領域高度以研究為導向，為學術實驗室和健康新興企業提供合作開發新產品的機會。

  • 人們正在尋求多學科和跨學科的方法，包括紡織貼片、相容的聚合物醫療植入和增強型個人防護裝備。進一步的研究和應用領域包括靜電紡奈米纖維、3D 列印、聚合物和抗菌塗層。
  • 該領域在整個紡織及相關行業的研發、產品開發以及與監管機構的合作方面擁有研究機會。此欄位有多個領域，可根據您的可自訂需求進行應用。

生物醫用紡織品市場促進因素

  • 心血管疾病增加

由於生活方式的改變，心血管疾病在全世界不斷增加。吸煙、不健康飲食、久坐的生活方式、缺乏運動和過量攝取等行為風險因素也會增加風險因素。這會增加血壓、血糖、血脂和超重。這些因素會增加心血管疾病的風險。在美國，心血管疾病是男性、女性以及大多數種族和民族的人的第一大死因。根據疾病管制美國的數據，每 33 秒就有一人死於心血管疾病。

這些數字表明心臟病正在增加。人們越來越關注心臟健康和整體生活方式問題。由於心臟病的增加，心血管手術的數量也在增加。創新解決方案的應用帶來了無限的效能可能性。

此前，生物醫學紡織品僅限於傳統的主動脈瓣修復移植物和心臟瓣膜縫合袖口。然而，心臟瓣膜織物解決方案現在用於多種應用。生物醫學紡織品的複雜應用可用於受損心血管組織的癒合和再生。我們可以生產主動脈弓加固、覆膜支架、頸動脈修復織物、生物相容性心臟瓣膜織物等。

Confluence Medical Technologies 開發和製造用於各種應用（包括心血管）的植入式紡織品。該公司生產用於主動脈瓣和二尖瓣的經導管瓣膜裙部、用於心耳阻塞設備的敷料以及血管內血管支架。該公司還生產儀器框架上的無縫編織配件，無需縫紉或手工組裝。

  • 擴大整形外科應用

骨科生物技術的進步提供了具有所需機械和生物效益的合成生物材料。這可應用於骨移植和融合、脊椎運動的維持、組織固定以及軟骨、肌腱、韌帶和半月軟骨的修復。在整形外科，患者的年齡層正在轉變為年輕患者。

這些人體力活動較多，容易造成軟組織損傷，包括韌帶和肌腱損傷。所有這些傷害都與運動、健身房、健行、騎自行車和其他冒險活動有關。身體活動相關的傷害在這一人群中變得非常普遍，導致需要進行手術。趨勢是避免大手術、早期療育和微創設備。

紡織品在整形外科的主要優勢在於其微創性、形狀變形、高拉伸強度、結構穩定性、生物相容性、柔韌性、多孔性、能夠透過小孔進入並在體內擴張等關鍵特性。一些生物醫學結構的幾何形狀可以客製化以影響孔隙率和組織整合，或作為組織屏障。這些結構具有固有的可壓縮和可形狀變形的特性，使其適用。應用包括運動縫合線和組件、關節和韌帶固定和重組裝置以及脊椎融合繫繩。

生物醫用紡織品 - 地理視角

  • 在預測期內，亞太地區將主導生物醫用紡織品市場。

中國、日本、印度、韓國等主要經濟體在亞太地區佔據主導地位。這一地區也包括東南亞國協等快速發展的新興國家。印度醫療保健產業持續強勁成長和擴張，私營和政府部門的產值均達到 3,720 億美元。

該行業是該國最大的雇主，截至 2024 年僱用了 750 萬人。印度醫療保健公共支出佔 GDP 的比重從 2021 會計年度的 1.6% 增加到 2.1%（2023 會計年度）和 2.2%（2022 會計年度）。 2024年醫療旅遊市場規模預估為76.9億美元。這些不斷增加的數字清楚地表明醫療設備應用範圍不斷擴大和創新產品的開發。

此外，中國是全球第二大醫療保健市場，醫療設備是重要的醫療保健銷售力量。根據國際貿易管理局官網數據顯示，中國醫療設備市場預計將以8.3%的複合年成長率擴張，到2026年將達到488億美元。由於生物醫學紡織品用於心血管、整形外科和組織工程等多種用途，對生物醫學紡織品的需求可能會增加。

生物醫用紡織品市場的限制因素：

  • 生物醫用紡織品難以採購和製造，因此專門從事該領域的公司具有優勢。製造和設計的複雜性對於該領域的老字型大小企業來說可能是一個優勢。
  • 這對於必須進行價格競爭的新公司來說是一個挑戰。由於需要高水準的研發，市場的快速成長受到限制。

生物醫用紡織品市場的主要發展：

  • 2024 年 1 月，Cortland Biomedical 增加了兩台提花織機，擴大了其織造能力。這將增強我們設計和開發織造醫學紡織品結構的能力和能力。這項策略舉措為醫用紡織品的進步開闢了新途徑。 Cortland Biomedical 保證與線張緊系統的完美連接。平紋和窄紋織物，包括梭織和劍桿織造，可用於創建用於血管移植等應用的3D結構。 Cortland Biomedical 利用多年的醫用紡織工程（包括針織、編織和機織）經驗來設計、客製化和製造高性能生物醫用紡織結構。
  • 2023 年 3 月，Riverpoint 宣布將透過帝斯曼生物醫學的獨家許可擴大其生物產品供應。 Riverpoint Medical 目前持有帝斯曼生物醫學獨家授權的專有骨傳導 (OC) 塗層技術。骨傳導是指骨頭在表面生長並隨著時間的推移被新骨頭取代。該公司創造了一種可以改善促進骨附著的環境的產品。骨傳導塗層用於整形外科和牙科植入，現在也用於可植入紡織產品。這是整形外科的突破，其中骨傳導支架是修復的重點。 Riverpoint Medical 和 DSM Biomedical 專有的 OC 塗層技術改善了外科醫生和患者的植入式紡織品。
  • 2022 年 10 月，Cortland Biomedical 推出了一種包含滲透性線纖維的紡織結構。該公司目前能夠加工滲透性纖維。在診斷應用中使用滲透性纖維可以使儀器在螢光鏡下可視化，並具有適合其預期用途的機械性能。這允許外科醫生定位器械。手術放置後數月甚至數年可透過螢光鏡檢查來確認可見度。該公司廣泛的針織、機織和編織能力使其能夠創造具有特定機械性能的複雜和客製化的紡織結構。目前，滲透性纖維有 PET 和 UHMWPE 兩種材質。

生物醫用紡織品市場細分與分析如下：

依纖維類型

  • 非生物分解纖維
  • 生物分解性纖維

按布料類型

  • 編織
  • 織物
  • 不織布
  • 其他

按用途

  • 心血管
  • 血管內的
  • 整形外科
  • 神經血管的
  • 縫合
  • 其他

按地區

  • 北美洲
  • 南美洲
  • 歐洲
  • 中東/非洲
  • 亞太地區

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
    • 心血管疾病增加
    • 擴大整形外科應用
    • 人口老化加劇
  • 市場限制因素
    • 設計和製造複雜性
  • 波特五力分析
  • 產業價值鏈分析

第5章生物醫用紡織品市場：依纖維類型

  • 介紹
  • 非生物分解纖維
  • 生物分解性纖維

第6章生物醫用紡織品市場：依布料類型

  • 介紹
  • 編織
  • 織物
  • 不織布材料
  • 其他

第7章生物醫用紡織品市場：依應用分類

  • 介紹
  • 心血管
  • 血管內的
  • 整形外科
  • 神經血管的
  • 縫合
  • 其他

第8章生物醫用紡織品市場：按地區

  • 世界概況
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東/非洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他亞太地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • Poly-Med Incorporated
  • Medical Murray
  • Bally Ribbon Mills
  • Swicofil AG
  • Royal DSM
  • Confluent Medical Technologies
  • 3M
  • Atex Technologies
  • Aran Biomedical Teoranta
  • Freudenberg Group
  • Trelleborg
  • Asahi Kasei Corporation
  • Elkem Silicones
  • Cortland Biomedical
簡介目錄
Product Code: KSI061616917

The global biomedical textiles market will grow at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2024 to 2029.

The global biomedical textiles market is driven by several core factors, including increasing cardiovascular diseases, orthopedics, spinal, and other disorders. According to the United Nations, the global population aged 65 and above is expected to rise from 10% in 2022 to 16% in 2050. The older population will surpass the number of children under age 5 by 2050. This is creating serious health-related issues for a large section of the population related to orthopedics, cardiovascular, etc., and causing the need for innovative health products like biomedical textiles. The biomedical textiles market sector is highly research-based and provides opportunities for academic research laboratories and health startups to collaborate and develop new products.

  • There has been a push for inter- and trans-disciplinary approaches, in using textiles for patches, compatible polymer-based medical implants, and PPE with enhanced functionalities. Further domains for research and application are electrospun nanofibers, 3D printing, polymers, antibacterial coatings, etc.
  • The sector has opportunities for research through the industries for textiles and allied fields in R&D, product development, and working with regulatory bodies. This sector has multiple domains for application according to customizable needs.

BIOMEDICAL TEXTILES MARKET DRIVERS:

  • Growing cases of cardiovascular diseases-

Cardiovascular diseases are rising worldwide owing to the changing lifestyles. Behavioral risk factors such as tobacco use, unhealthy diet, sedentary lifestyle, physical inactivity, and overuse of alcohol are giving thrust to the risk factors. This causes raised blood pressure, blood glucose, blood lipids, and overweight. The risk of cardiovascular diseases has been increasing due to these factors. In the United States, cardiovascular diseases are the leading cause of death for men, women, and people of most racial and ethnic groups. According to the Centers for Disease Control, one person dies every 33 seconds from cardiovascular disease.

These figures indicate the increasing cases of heart diagnoses. People are becoming concerned about their heart health and overall lifestyle challenges. The growing number of heart diseases is causing an increasing number of heart surgeries. Innovative solutions have been applied to the limitless performance possibilities.

Earlier, biomedical textiles were limited to vascular grafts and heart valve sewing cuffs for traditional aortic valve repair. But now, heart valve fabric solutions are used in multiple applications. The complex application of biomedical textiles can be used for the healing and regeneration of damaged cardiovascular tissue. It can generate aortic arch reinforcement, stent graft covering, carotid artery repair fabric, and biocompatible heart valve fabric, among others.

Confluent medical technologies are developing and manufacturing implantable textiles for various applications, including cardiovascular. The company makes aortic and mitral transcatheter valve skirts, atrial appendage occlusion device coverts, or endovascular stent grafts. It also produces sutureless attachments of textiles to a device frame which eliminates the need for sewing and manual assemblies.

  • Growing application in orthopedics-

The advancement in orthobiologics provides synthetic biomaterials for the required mechanical and biological benefits. This can be applied for bone grafting and fusion, motion preservation in the spine, tissue fixation, cartilage, tendon, ligament, and meniscal repair. In the orthopedic, there has been a shift in the age demographics toward more younger patients.

These people are more physically active, causing soft-tissue injuries, including damage to the ligaments and tendons. All these injuries are associated with sports, gym, adventure like trekking, cycling, etc. Physical activity-related injuries are becoming very common among these populations, thus leading to surgeries. The trend is moving towards avoiding large-scale surgeries, earlier intervention, and less invasive devices.

Key benefits of textiles in orthopedics can be attributed to key features like less invasiveness, shape transformation, high tensile strength, stable structure, biocompatibility, flexibility, porosity, and features like entering through a small hole and then expanding in the body, among others. The geometry of several biomedical structures can be customized to affect porosity and tissue integration or act as a tissue barrier. These structures have applications due to their inherently compressible and shape-transformable properties. The application can be in sports med sutures and assemblies, joint and ligament fixation and reconstruction devices, and spinal fixation tethers.

BIOMEDICAL TEXTILES MARKET - GEOGRAPHICAL OUTLOOK

  • Asia Pacific region to dominate the biomedical textiles market during the forecast period.

The major economies like China, Japan, India, and South Korea dominate the Asia-Pacific region. Some of the fastest-growing emerging economies are from this region, such as ASEAN countries. The Indian Healthcare industry continued to show robust growth and expansion, reaching a value of US$372 billion both in the private sector and the government.

This sector has been the largest employer in the country, with 7.5 million as of 2024. India's public expenditure on healthcare touched 2.1 % of GDP in FY23 and 2.2% in FY22, a rise from 1.6% in FY21. The country's medical tourism market is valued at US$7.69 billion in 2024. These increased numbers significantly indicate the growing application of medical devices and development of the innovative products.

Additionally, China is the world's second-largest healthcare market, making medical devices an important healthcare sales. According to the Official Website of the International Trade Administration, the medical device market in China is expected to expand at a Compound Annual Growth Rate (CAGR) of 8.3%, making it US$48.8 billion by 2026. The biomedical textiles being used in the multipurpose applications of cardiovascular, orthopedic, and tissue engineering would likely rise in demand.

Biomedical Textiles Market Restraints:

  • Biomedical textiles are difficult to source and manufacture, this keeps the companies that are specialized in this segment better situated. The complexity of manufacturing and designing could be an added advantage for the well-established companies in this segment.
  • This is a challenge for new companies, which must compete on price. The high research and development required is limiting the fast market growth.

Biomedical textiles market Key Developments:

  • In January 2024, Cortland Biomedical expanded its weaving capabilities by incorporating two additional jacquard looms. It enhances the capabilities and capacity to design and develop woven biomedical textile structures. This strategic move will give new avenues for advancements in medical textiles. Cortland Biomedical ensures excellence in contact surfaces to yarn tensioning systems. Plain and narrow weave fabrics, including shuttle and rapier weaving, could help create three-dimensional structures for applications like vascular grafts. Cortland Biomedical designs, customizes, and manufactures high-performance biomedical textile structures with years of experience in medical textile engineering, including knitting, braiding, and weaving.
  • In March 2023, Riverpoint announced the expansion of biological offerings with the exclusive license of DSM biomedicals. Riverpoint Medical now has the exclusive licensed proprietary osteoconductive (OC) coating technology from DSM Biomedical. Osteoconduction is when bone grows on a surface and replaces it with new bone over time. The company made a product that can improve the environment for enhanced bone attachment. Osteoconductive coatings are used in orthopedic and dental implants and now in implantable textiles. This is a breakthrough in the orthopedic space where an osteoconductive scaffold is at the point of repair. The proprietary OC coating technology by Riverpoint Medical and DSM Biomedical improved implantable textiles for both surgeons and patients.
  • In October 2022, Cortland Biomedical announced textile structures incorporating radiopaque fibers. It can now process radiopaque fibers. By putting radiopaque fibers into diagnostic, it can allow devices to be visible under fluoroscopy, with their mechanical properties for the application. This will allow surgeons to position the device. Visibility can be seen through fluoroscopy months or years after surgical placement. The company's extensive range of knitting, weaving, and braiding capabilities enables it to make complex and customized textile structures with specific mechanical properties. Radiopaque fibers are currently available in PET and UHMWPE.

The biomedical textiles market is segmented and analyzed as follows:

By Fiber Type

  • Non-biodegradable Fiber
  • Biodegradable Fiber

By Fabric Type

  • Braided
  • Woven Materials
  • Non-Woven Materials
  • Others

By Application

  • Cardiovascular
  • Endovascular
  • Orthopedics
  • Neurovascular
  • Suture
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Middle East and Africa
  • Asia-Pacific

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
    • 4.1.1. Growing cases of cardiovascular diseases
    • 4.1.2. Growing application in orthopedics
    • 4.1.3. Growing geriatric population
  • 4.2. Market Restraints
    • 4.2.1. Complexity in design and manufacturing
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. BIOMEDICAL TEXTILES MARKET BY FIBER TYPE

  • 5.1. Introduction
  • 5.2. Non-biodegradable Fiber
  • 5.3. Biodegradable Fiber

6. BIOMEDICAL TEXTILES MARKET BY FABRIC TYPE

  • 6.1. Introduction
  • 6.2. Braided
  • 6.3. Woven Materials
  • 6.4. Non-Woven Materials
  • 6.5. Others

7. BIOMEDICAL TEXTILES MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Cardiovascular
  • 7.3. Endovascular
  • 7.4. Orthopedics
  • 7.5. Neurovascular
  • 7.6. Suture
  • 7.7. Others

8. BIOMEDICAL TEXTILES MARKET BY GEOGRAPHY

  • 8.1. Global Overview
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Rest of South America
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Rest of Europe
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. United Arab Emirates
    • 8.5.3. Rest of Middle East and Africa
  • 8.6. Asia-Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Rest of Asia-Pacific

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Poly-Med Incorporated
  • 10.2. Medical Murray
  • 10.3. Bally Ribbon Mills
  • 10.4. Swicofil AG
  • 10.5. Royal DSM
  • 10.6. Confluent Medical Technologies
  • 10.7. 3M
  • 10.8. Atex Technologies
  • 10.9. Aran Biomedical Teoranta
  • 10.10. Freudenberg Group
  • 10.11. Trelleborg
  • 10.12. Asahi Kasei Corporation
  • 10.13. Elkem Silicones
  • 10.14. Cortland Biomedical